W/ $4.8 cash/ share and major catalyst should hit anytime too, that's a strong buy to me. Could have sold yesterday but its pretty obvious this stock is going much higher. Far away from bottom ( 2.6) on a bullish uptrend for solid reasons.
Had $10m net assets (last 10Q, mostly cash on hand) just funded for more $26.8m. vs $20m MC.
the Chairman, invested $1.7M recently. way undervalued relating Equity and Market Potential (As described in yesterday's Letter to Shareholders).very recommended at current price.
Pipeline in Progressive Stages
Phase 3
• Lead product (Mino-Lok) is a unique antibiotic lock therapy that salvages central lines in bacteremic patients, has been granted QIDP, and is in Phase 3. There is no approved competition nor any on the horizon. We estimate the market to be >$1 billion worldwide.
Phase 2
• Gastrointestinal product (topical hemorrhoid symptomatic treatment) Phase 2a completed with positive directional results showing improvement over components and vehicle. This product would be the only FDA approved Rx therapy for hemorrhoids. Market is >4 million Rxs and we estimate the dollar market to be >$1 billion in US.
ü Targeted Acquisitions
• Business development activity focused on adjunctive cancer care (infection, chronic pain, nausea, etc.). Fast growing segment with exceptional opportunities.
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
